Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

View:
Post by megatron9191 on Oct 24, 2023 10:31am

Question

If Baxter does end up buying out the company when it reaches 90 patients, is there a possibility that shareholders are now awarded Baxter stock (which is valued at around $30)? How does the pay out work to the stakeholders?
Comment by oilandgasman on Oct 24, 2023 10:42am
Nice chart.. 87.00 bucks in Jan 2022 Baxter stock has been in free fall mode for the past two years.
Comment by MMABStrader on Oct 24, 2023 2:40pm
If Baxter's buyout offer is at a price of $3.00 a share to Spectral shareholders (but it is not a cash buyout but an exchange of Baxter shares for Spectral shares); and, if at the time of the buyout offer Baxter shares were trading at $30 a share, Baxter would offer Spectral shareholders one share of Baxter stock for every ten shares Spectral shareholders own, i.e. one Baxter share for ten ...more  
Comment by Accountprince on Oct 24, 2023 4:27pm
If Baxter is trading at $30 then yes 1 Baxter shares for 10 Spectral shares.  But Baxter's share price is in USD.  So at an exchange rate of 1.35 the Spectral shares should trade at $4.05 a share (US$3.00 at 1.35).
Comment by MMABStrader on Oct 24, 2023 4:46pm
I'm in the U.S. and I buy Spectral shares on the OTC. In my Baxter buy out example I was thinking of U.S. dollars for both sides of the transaction.  I was assuming a buyout of Spectral at around $1.3 billion Canadian.
Comment by mercedesman on Oct 25, 2023 12:02am
Yes essentially $3 US =  $4.00 Cdn per share. And based on 1/3 of a billion shares o/s.  Makes sense, although perhaps a tiny bit low on buyout price, relative to true valuation and potential ( much is dependent on final Tigris results and mortality benefit, Eden results, etc. all of which likely impacts future PMX price, disposition of the FDA approved companion diagnostic, iDialco, ...more  
Comment by Revten on Oct 25, 2023 11:34am
Very True MM. Potential will Also Be "Exceeding Expectations" IMHO And also a great question regarding the OTC Trading & Exposure etc... Thanks! Rev
Comment by MMABStrader on Oct 25, 2023 11:57am
I picked the $3 U.S. buyout price to make it simple to explain what would happen in a Baxter buyout. Personally, I believe the ultimate buyout price will be between $3 and $5 U.S. It is easy to buy Spectral shares on the OTC as long as you are willing to buy shares at the ask price. In my Ameritrade account I can buy any quantity of EDTXF for a $3.95 commission. 
Comment by mercedesman on Oct 25, 2023 10:04pm
Thx Med...trader I was curious how much news flow on Spectral makes it there and the likelihood that an average investor might stumble upon it.  It's a difficult stock to do your DD on , not to mention the mercurial nature of Sepsis itself and the difficulty in pinning down a solution particularly using a traditional 28-day mortality RCT to do so.  MM 
Comment by MMABStrader on Oct 26, 2023 2:11pm
Mercedesman... There is very little info regarding Spectral that reaches the U.S.  I'm on Spectral's mailing list so I get emails for all announcements that Spectral makes.  I also occasionally vist Spectral's web site to see any new content they add to the site. I also read the Canadian chat board postings for Spectral. I was previously an investor in BioMS. I sold my ...more  
Comment by mercedesman on Oct 28, 2023 9:37am
Thx MBAB You are not unlike the typical non- insider Cdn. retail shareholder.  A small number of long term ( and largish)  holders going back to the BioMS days   Very little information reaches the Cdn investment community either. And the company story, like Sepsis itself, is not straightforward nor well-known outside the ICU/ medical community  That is obviously the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities